Cargando…

The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states

The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujinami, Daisuke, -Mahin, Abdullah-Al, Elsayed, Khaled M., Islam, Mohammad R., Nagao, Jun-ichi, Roy, Urmi, Momin, Sabrina, Zendo, Takeshi, Kohda, Daisuke, Sonomoto, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156582/
https://www.ncbi.nlm.nih.gov/pubmed/30272026
http://dx.doi.org/10.1038/s42003-018-0150-3
_version_ 1783358134497050624
author Fujinami, Daisuke
-Mahin, Abdullah-Al
Elsayed, Khaled M.
Islam, Mohammad R.
Nagao, Jun-ichi
Roy, Urmi
Momin, Sabrina
Zendo, Takeshi
Kohda, Daisuke
Sonomoto, Kenji
author_facet Fujinami, Daisuke
-Mahin, Abdullah-Al
Elsayed, Khaled M.
Islam, Mohammad R.
Nagao, Jun-ichi
Roy, Urmi
Momin, Sabrina
Zendo, Takeshi
Kohda, Daisuke
Sonomoto, Kenji
author_sort Fujinami, Daisuke
collection PubMed
description The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively.
format Online
Article
Text
id pubmed-6156582
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61565822018-09-28 The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states Fujinami, Daisuke -Mahin, Abdullah-Al Elsayed, Khaled M. Islam, Mohammad R. Nagao, Jun-ichi Roy, Urmi Momin, Sabrina Zendo, Takeshi Kohda, Daisuke Sonomoto, Kenji Commun Biol Article The lantibiotic nukacin ISK-1 exerts antimicrobial activity through binding to lipid II. Here, we perform NMR analyses of the structure of nukacin ISK-1 and the interaction with lipid II. Unexpectedly, nukacin ISK-1 exists in two structural states in aqueous solution, with an interconversion rate on a time scale of seconds. The two structures differ in the relative orientations of the two lanthionine rings, ring A and ring C. Chemical shift perturbation induced by the titration of lipid II reveals that only one state was capable of binding to lipid II. On the molecular surface of the active state, a multiple hydrogen-bonding site formed by amino acid residues in the ring A region is adjacent to a hydrophobic surface formed by residues in the ring C region, and we propose that these sites interact with the pyrophosphate moiety and the isoprene chain of the lipid II molecule, respectively. Nature Publishing Group UK 2018-09-25 /pmc/articles/PMC6156582/ /pubmed/30272026 http://dx.doi.org/10.1038/s42003-018-0150-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Fujinami, Daisuke
-Mahin, Abdullah-Al
Elsayed, Khaled M.
Islam, Mohammad R.
Nagao, Jun-ichi
Roy, Urmi
Momin, Sabrina
Zendo, Takeshi
Kohda, Daisuke
Sonomoto, Kenji
The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
title The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
title_full The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
title_fullStr The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
title_full_unstemmed The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
title_short The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states
title_sort lantibiotic nukacin isk-1 exists in an equilibrium between active and inactive lipid-ii binding states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156582/
https://www.ncbi.nlm.nih.gov/pubmed/30272026
http://dx.doi.org/10.1038/s42003-018-0150-3
work_keys_str_mv AT fujinamidaisuke thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT mahinabdullahal thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT elsayedkhaledm thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT islammohammadr thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT nagaojunichi thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT royurmi thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT mominsabrina thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT zendotakeshi thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT kohdadaisuke thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT sonomotokenji thelantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT fujinamidaisuke lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT mahinabdullahal lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT elsayedkhaledm lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT islammohammadr lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT nagaojunichi lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT royurmi lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT mominsabrina lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT zendotakeshi lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT kohdadaisuke lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates
AT sonomotokenji lantibioticnukacinisk1existsinanequilibriumbetweenactiveandinactivelipidiibindingstates